Jussi Rytkönen

615 total citations
16 papers, 448 citations indexed

About

Jussi Rytkönen is a scholar working on Materials Chemistry, Biomedical Engineering and Molecular Biology. According to data from OpenAlex, Jussi Rytkönen has authored 16 papers receiving a total of 448 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Materials Chemistry, 6 papers in Biomedical Engineering and 4 papers in Molecular Biology. Recurrent topics in Jussi Rytkönen's work include Silicon Nanostructures and Photoluminescence (6 papers), Graphene and Nanomaterials Applications (5 papers) and Nanoparticle-Based Drug Delivery (2 papers). Jussi Rytkönen is often cited by papers focused on Silicon Nanostructures and Photoluminescence (6 papers), Graphene and Nanomaterials Applications (5 papers) and Nanoparticle-Based Drug Delivery (2 papers). Jussi Rytkönen collaborates with scholars based in Finland, United States and Estonia. Jussi Rytkönen's co-authors include Ale Närvänen, Jarno Salonen, Ermei Mäkilä, Hélder A. Santos, Vesa‐Pekka Lehto, Martti Kaasalainen, Jouni Hirvonen, Wujun Xu, Luís M. Bimbo and Päivi Laaksonen and has published in prestigious journals such as Chemistry of Materials, Stroke and Langmuir.

In The Last Decade

Jussi Rytkönen

16 papers receiving 442 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jussi Rytkönen Finland 10 182 147 141 118 56 16 448
Ankshita Prasad Singapore 11 175 1.0× 117 0.8× 146 1.0× 97 0.8× 119 2.1× 13 553
Qi Cai China 14 203 1.1× 107 0.7× 133 0.9× 92 0.8× 33 0.6× 33 508
Nina Ehlert Germany 10 190 1.0× 73 0.5× 114 0.8× 111 0.9× 32 0.6× 28 443
Christopher Rathnam United States 11 259 1.4× 192 1.3× 87 0.6× 70 0.6× 67 1.2× 17 519
Halil Bayraktar Türkiye 12 152 0.8× 186 1.3× 97 0.7× 137 1.2× 43 0.8× 24 609
Andrea Degl’Innocenti Italy 14 370 2.0× 163 1.1× 153 1.1× 206 1.7× 69 1.2× 24 665
Barry J. Liang United States 10 231 1.3× 178 1.2× 85 0.6× 108 0.9× 100 1.8× 13 571
Helen Forgham Australia 12 244 1.3× 168 1.1× 98 0.7× 170 1.4× 17 0.3× 24 527
Po‐Hung Hsu Taiwan 14 639 3.5× 172 1.2× 223 1.6× 193 1.6× 70 1.3× 20 885
Anna Lagunas Spain 17 350 1.9× 164 1.1× 111 0.8× 126 1.1× 66 1.2× 46 717

Countries citing papers authored by Jussi Rytkönen

Since Specialization
Citations

This map shows the geographic impact of Jussi Rytkönen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jussi Rytkönen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jussi Rytkönen more than expected).

Fields of papers citing papers by Jussi Rytkönen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jussi Rytkönen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jussi Rytkönen. The network helps show where Jussi Rytkönen may publish in the future.

Co-authorship network of co-authors of Jussi Rytkönen

This figure shows the co-authorship network connecting the top 25 collaborators of Jussi Rytkönen. A scholar is included among the top collaborators of Jussi Rytkönen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jussi Rytkönen. Jussi Rytkönen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
2.
Johnson, Tyler B., Kimmo Lehtimäki, Jacob T. Cain, et al.. (2020). A multimodal approach to identify clinically relevant biomarkers to comprehensively monitor disease progression in a mouse model of pediatric neurodegenerative disease. Progress in Neurobiology. 189. 101789–101789. 5 indexed citations
3.
Huhtala, Tuulia, Pekka Poutiainen, Jussi Rytkönen, et al.. (2019). Improved synthesis of [18F] fallypride and characterization of a Huntington’s disease mouse model, zQ175DN KI, using longitudinal PET imaging of D2/D3 receptors. EJNMMI Radiopharmacy and Chemistry. 4(1). 20–20. 9 indexed citations
4.
Cui, Lili, Franziska Nitzsche, Evgeny Pryazhnikov, et al.. (2017). Integrin α4 Overexpression on Rat Mesenchymal Stem Cells Enhances Transmigration and Reduces Cerebral Embolism After Intracarotid Injection. Stroke. 48(10). 2895–2900. 51 indexed citations
5.
Rytkönen, Jussi, et al.. (2016). 776 Prostate cancer incidence and cardiovascular mortality among users of testosterone replacement therapy in the Finnish Prostate Cancer Screening Trial. European Urology Supplements. 15(3). e776–e776. 1 indexed citations
6.
Kaasalainen, Martti, Jussi Rytkönen, Ermei Mäkilä, Ale Närvänen, & Jarno Salonen. (2015). Electrostatic Interaction on Loading of Therapeutic Peptide GLP-1 into Porous Silicon Nanoparticles. Langmuir. 31(5). 1722–1729. 31 indexed citations
7.
Vlasova, M. A., Jussi Rytkönen, Joakim Riikonen, et al.. (2014). Nanocarriers and the delivered drug: Effect interference due to intravenous administration. European Journal of Pharmaceutical Sciences. 63. 96–102. 6 indexed citations
8.
Rytkönen, Jussi, Tuomo Nissinen, Joakim Riikonen, et al.. (2014). Improved stability and biocompatibility of nanostructured silicon drug carrier for intravenous administration. Acta Biomaterialia. 13. 207–215. 57 indexed citations
9.
Wang, Chang‐Fang, Ermei Mäkilä, Colin Bonduelle, et al.. (2014). Functionalization of Alkyne-Terminated Thermally Hydrocarbonized Porous Silicon Nanoparticles With Targeting Peptides and Antifouling Polymers: Effect on the Human Plasma Protein Adsorption. ACS Applied Materials & Interfaces. 7(3). 2006–2015. 31 indexed citations
10.
Xu, Wujun, Jussi Rytkönen, Seppo Rönkkö, et al.. (2014). A Nanostopper Approach To Selectively Engineer the Surfaces of Mesoporous Silicon. Chemistry of Materials. 26(23). 6734–6742. 25 indexed citations
11.
Huhtala, Tuulia, Janne Weisell, Jussi Rytkönen, & Ale Närvänen. (2013). Peptide Labelling Strategies for Imaging Agents. Methods in molecular biology. 1088. 171–183. 2 indexed citations
12.
Rytkönen, Jussi, Piret Arukuusk, Wujun Xu, et al.. (2013). Porous Silicon–Cell Penetrating Peptide Hybrid Nanocarrier for Intracellular Delivery of Oligonucleotides. Molecular Pharmaceutics. 11(2). 382–390. 20 indexed citations
13.
Langel, Kent, Johan Runesson, Jaak Järv, et al.. (2013). Novel systemically active galanin receptor 2 ligands in depression‐like behavior. Journal of Neurochemistry. 127(1). 114–123. 39 indexed citations
14.
Sarparanta, Mirkka, Luís M. Bimbo, Jussi Rytkönen, et al.. (2012). Intravenous Delivery of Hydrophobin-Functionalized Porous Silicon Nanoparticles: Stability, Plasma Protein Adsorption and Biodistribution. Molecular Pharmaceutics. 9(3). 654–663. 115 indexed citations
15.
Huhtala, Tuulia, Jussi Rytkönen, Anu Jalanko, et al.. (2012). Native and Complexed IGF-1: Biodistribution and Pharmacokinetics in Infantile Neuronal Ceroid Lipofuscinosis. Journal of Drug Delivery. 2012. 1–8. 7 indexed citations
16.
Rytkönen, Jussi, Riitta Miettinen, Martti Kaasalainen, et al.. (2012). Functionalization of Mesoporous Silicon Nanoparticles for Targeting and Bioimaging Purposes. Journal of Nanomaterials. 2012(1). 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026